V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014707 | 270010518 | 1.75 | 67.2 | Palliative (P) | 2016-01-26 | 2016-02-04 | IDELALISIB | N | null | 270022919 | CVP R |
| 270014708 | 270010519 | 1.68 | 69.8 | Not known (9) | 2018-02-14 | 2018-03-22 | Bortezomib + Panobinostat | N | N | 270022921 | FLUDARABINE + MELPHALAN |
| 270014709 | 270010519 | 1.55 | 54.9 | Adjuvant (A) | 2015-02-08 | 2015-02-24 | VINCRISTINE | N | N | 270022921 | BLEOMYCIN |
| 270014710 | 270014914 | 1.75 | 61.9 | null | 2018-03-18 | 2018-03-19 | LOPP | 2 | N | 270022948 | CHLVPP/PABLOE |
| 270014711 | 270010521 | 1.72 | 47 | Curative (C) | 2016-12-01 | 2016-12-16 | CARBOPLATIN + RT | 02 | N | 270022966 | BENDAMUSTINE + RITUXIMAB |
| 270014712 | 270014915 | 1.68 | 68.1 | Curative (C) | 2015-10-18 | 2015-11-07 | RATHL TRIAL | N | N | 270022967 | IMATINIB |
| 270014713 | 270010522 | 1.83 | 61.9 | Disease modification (D) | 2017-01-29 | 2017-06-18 | Ifosfamide | N | N | 270022977 | CYCLOPHOSPHAMIDE |
| 270014714 | 270010523 | null | null | Not known (9) | 2013-12-10 | 2013-12-27 | CHOP - 21 days | N | N | 270022978 | R CODOX-M/ R IVAC |
| 270014715 | 270010523 | 1.51 | 51.3 | Not known (9) | 2014-09-23 | 2015-05-27 | GEMCITABINE + VINORELBINE | N | N | 270022978 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270014716 | 270010526 | 1.7 | null | Not known (9) | 2016-08-05 | 2017-02-15 | CVD | null | N | 270022987 | DHAP - R |
| 270014717 | 270010528 | 1.62 | 57.5 | Curative (C) | 2016-08-22 | 2016-10-31 | ESHAP R | N | 2 | 270023031 | CYCLOPHOSPHAMIDE |
| 270014718 | 270014919 | 1.61 | 66 | Curative (C) | 2014-02-01 | 2014-02-24 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE | N | Y | 270023031 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270014721 | 270018540 | 1.86 | 56 | Palliative (P) | 2017-12-20 | 2018-01-03 | CVP R | 02 | Y | 270023072 | CVP R |
| 270014722 | 270019293 | 1.78 | 97.9 | Curative (C) | 2019-02-12 | 2019-02-18 | Cyclophosphamide+Fludara+TBI Allo | N | N | 270023120 | CVP R |
| 270014723 | 270019719 | 1.84 | null | null | 2017-12-17 | 2017-12-22 | ICE | 02 | N | 270023120 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270014724 | 270010532 | 1.76 | 70 | Curative (C) | 2015-07-10 | 2015-09-08 | BLEOMYCIN | N | N | 270023126 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014725 | 270014922 | 1.7 | 102.9 | Curative (C) | 2014-09-06 | 2014-09-13 | TEMOZOLOMIDE | N | N | 270023130 | PACLITAXEL |
| 270014726 | 270017231 | 1.96 | null | Palliative (P) | 2017-05-25 | 2017-07-12 | CHLORAMBUCIL + DEXAMETHASONE + DEXAMETHASONE + ETOPOSIDE | N | null | 270023155 | BORTEZOMIB + PANOBINOSTAT |
| 270014727 | 270010535 | 1.62 | 59.2 | null | 2015-08-05 | 2015-08-05 | LENALIDOMIDE | N | N | 270023156 | ETOPOSIDE |
| 270014728 | 270014923 | 1.62 | null | Curative (C) | 2016-05-06 | 2016-05-13 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270023156 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 270014729 | 270014923 | 1.61 | 48.7 | Curative (C) | 2015-06-15 | 2015-06-16 | ICE-R | 02 | null | 270023156 | TEMOZOLOMIDE |
| 270014730 | 270014924 | 1.69 | 49.4 | Curative (C) | null | 2016-12-11 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 270023166 | BREVITY TRIAL |
| 270014731 | 270010545 | null | null | Palliative (P) | 2014-08-28 | 2014-10-19 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE | N | N | 270023172 | ICE-R |
| 270014732 | 270014926 | 1.72 | 54.6 | Curative (C) | 2015-03-28 | 2015-03-29 | RATHL TRIAL | N | N | 270023185 | ICE-R |
| 270014733 | 270010548 | 1.6 | 64.3 | Curative (C) | 2016-02-27 | 2016-03-01 | LENALIDOMIDE | 02 | N | 270023195 | MPT |
| 270014734 | 270010550 | 1.8 | null | null | 2016-11-29 | 2016-12-06 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | Y | 270023205 | CISPLATIN + CETUXIMAB |
| 270014735 | 270010551 | 1.7 | null | Palliative (P) | 2014-05-05 | 2014-05-05 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | 02 | N | 270023219 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270014736 | 270010551 | 1.82 | 63 | null | 2016-09-03 | 2016-09-04 | DOXORUBICIN | 02 | N | 270023219 | TEMOZOLOMIDE |
| 270014737 | 270010551 | 1.91 | 58 | null | 2017-09-01 | 2017-09-21 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 270023219 | GDP R |
| 270014738 | 270018543 | 1.83 | 78.7 | Curative (C) | 2015-04-23 | 2015-04-30 | R-GEM-P | 2 | N | 270023299 | LENALIDOMIDE |
| 270014739 | 270010553 | 1.62 | 43.8 | Palliative (P) | 2018-08-15 | 2018-09-17 | Methotrexate intrathecal | N | N | 270023300 | ICE |
| 270014740 | 270010554 | null | null | Adjuvant (A) | 2017-03-03 | 2017-03-11 | FEC 100 | 2 | N | 270023301 | CVP R |
| 270014741 | 270010556 | 1.8 | 61.9 | Palliative (P) | 2016-09-02 | 2016-09-02 | AFATINIB | N | N | 270023327 | PEMBROLIZUMAB |
| 270014742 | 270010557 | 1.71 | 76.4 | null | 2018-07-03 | 2018-07-10 | ICE + GCSF | 02 | N | 270023335 | ICE |
| 270014743 | 270014929 | 1.7 | 78.6 | null | 2016-09-20 | 2016-10-03 | Ifosfamide | 02 | N | 270023336 | ICE-R |
| 270014744 | 270010558 | 1.55 | 64.4 | Adjuvant (A) | 2016-08-06 | 2016-08-27 | CARBOPLATIN + GEMCITABINE | 2 | N | 270023353 | ECHELON 1 TRIAL |
| 270014745 | 270010563 | null | 70.1 | Curative (C) | 2017-01-09 | 2017-01-15 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 2 | null | 270023365 | NHL 2003 |
| 270014746 | 270010565 | 1.62 | 89 | Disease modification (D) | 2016-07-31 | 2016-08-03 | R GCVP | N | N | 270023375 | MELPHALAN |
| 270014747 | 270014932 | null | 84.6 | null | 2016-11-09 | 2016-11-10 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | N | N | 270023394 | CHLVPP/PABLOE |
| 270014748 | 270010566 | 1.68 | 72 | Palliative (P) | 2018-02-17 | 2018-02-23 | Mitoxantrone | 02 | N | 270023394 | PMITCEBO |
| 270014749 | 270017236 | 1.75 | 71.3 | Curative (C) | 2015-03-08 | 2015-03-14 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | N | null | 270023407 | CARBOPLATIN + ETOPOSIDE |
| 270014750 | 270018544 | 1.71 | 66 | Palliative (P) | 2014-12-16 | 2014-12-16 | ICE (no GCSF) | N | N | 270023407 | DOXORUBICIN |
| 270014751 | 270010570 | 1.76 | 61 | Curative (C) | 2018-04-17 | 2018-04-17 | IMATINIB | N | null | 270023443 | METHOTREXATE |
| 270014752 | 270010575 | 1.75 | 78.7 | Curative (C) | 2013-07-05 | 2013-07-12 | RATHL TRIAL | N | N | 270023461 | FLUDARABINE + MELPHALAN |
| 270014753 | 270010575 | null | 60.6 | Palliative (P) | 2014-04-22 | 2014-04-22 | ECHELON 1 TRIAL | N | N | 270023461 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 270014754 | 270010576 | 1.53 | 51.2 | Palliative (P) | 2014-06-15 | 2014-08-01 | Cytarabine HD + Methotrexate HD | N | N | 270023505 | GEMCARBO |
| 270014755 | 270010577 | 1.6 | 92 | Curative (C) | 2015-02-08 | 2015-02-12 | R GCVP | 02 | null | 270023517 | MELPHALAN |
| 270014756 | 270010579 | 1.68 | 0 | Adjuvant (A) | 2015-10-03 | 2015-10-18 | Fludarabine + Melphalan RIC Allo | 2 | N | 270023531 | BENDAMUSTINE + RITUXIMAB |
| 270014757 | 270010580 | 1.79 | 96.6 | Disease modification (D) | 2015-11-07 | 2015-11-09 | Gemcitabine + Oxaliplatin | 02 | N | 270023542 | CVP R |
| 270014758 | 270010582 | -1 | 49.4 | Curative (C) | 2016-05-14 | 2016-05-14 | ECHELON 1 TRIAL | N | N | 270023548 | CVP R |